Shocking! 1,705 deaths in Clinical Trials Since 2021, reveals RTI We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Health Bulletin 01/September/2025 We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
One Death a Day: 1,705 Lives Lost in India’s Clinical Trials Since 2021, RTI Reveals We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Eli Lilly has reported the results of a third phase 3 trial of oral weight-loss therapy orforglipron, clearing the way for regulatory filings around the world. The results of the ATTAIN-2 study, which involved people with obesity or overweight with type 2 diabetes, showed that the oral GLP-1 agonist achieved an average weight loss of…
CDSCO Digitisation Cuts Post-Approval Change Timelines in CGTs from 218 to 98 Days: DCGI We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Expert Panel Rejects Zuventus’ Trelagliptin PMS Plan, Seeks Higher Patient Enrolment We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link